On September 27, 2023, the Italian Ministry of Health released a decree with which they adopted the launch of the new national screening program, which will be launched in January 2024. The screening program will screen children for type 1 diabetes and celiac disease.

On October 10, 2023, NHS England published an updated work plan for specialized clinical commissioning policies development (as of October 2, 2023). Two MedTech-related policies were added to the program: Gamma Knife stereotactic radiosurgery for essential tremor in adults; Stereotactic Ablative Radiotherapy for the treatment of primary kidney cancer. The status of ongoing policies was updated.

In October 2023, the Norwegian Directorate of e-Health released the Norwegian Clinical Procedure Codes for 2024. The coding system consists of three parts: NCMP for medical procedures, NCSP for surgical, and NCRP for radiological procedures. A total of 28 new codes will be introduced from January 2024: 10 new surgical procedure codes, 14 new radiology procedure codes, and four new medical procedure codes.

In October 2023, the Centre for Assessment of Medical Technology in Örebro is working on several HTAs, including evaluations in e-health, ICU/OR, men’s health, orthopedic fields, and other fields.

The revised EBM (German Uniform Evaluation Standard) catalog came into force on October 1, 2023. The most significant changes concern the introduction of the new EBM codes for several IVD tests, prostate-specific membrane antigen (PSMA) positron emission tomography, as well as for stereotactic radiosurgery (SRS) in vestibular schwannomas.

UK patients will benefit from a £30 million government investment in innovative medical technology, which will help ease pressures on the NHS this winter. The Integrated care systems will be able to invest in the latest technology that can help cut waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients.

On September 21, 2023, the Dutch Organization for Health Research and Development (ZonMw) announced the submission of grant applications for the development or validation of methodology for labor deployment measurement and evaluation under the 2021-2024 HTA Methodology Program. The submission of grant applications will continue until January 9, 2024.

The so-called hybrid DRGs reimbursement mechanism will first cover services from the “starting catalog”, and it will be implemented at the beginning of 2024. The catalog itself is still not publicly available.

On September 28, 2023, the Dutch Healthcare Authority (NZa) published the second release of the DRG package for 2024 (RZ24b). One new procedure code, two new supplementary payments, and three new DRGs will be implemented across in-vitro diagnostics, urology, and cardiovascular technology groups.

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in September 2023. Twenty recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services (LPPR). Opinions concern, peripheral vascular and neurovascular, neurology and neurosurgery, ENT, spine, ophthalmology, and orthopedic devices, as well as medical aids.

The Danish Health Data Authority quarterly updates the Health Care Classification System (SKS). In September 2023, the latest code changes were published to come into force on October 1, 2023. Four surgical procedure codes concerning extracorporeal membrane oxygenation (ECMO) were introduced.

In September 2023, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (removal, preservation, and reimplantation of ovarian tissue for restoring fertility, transurethral water-jet ablation for lower urinary tract symptoms, cryotherapy for chronic rhinitis), and three Health Technology Evaluations using early value assessment (AI-derived software to analyze chest X-rays for suspected lung cancer, AI technologies to aid contouring for radiotherapy planning, KardiaMobile 6L for adults having antipsychotic medication). Also, two new clinical guidelines were published, and three were updated.